SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer.
0 references·6 citing·25 second hop
A clinical and pharmacodynamic evaluation of iproniazid as a psychic energizer. (1957)A clinical and pharmacodynamic evaluation…Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat (2015)Behavioural and neurotoxic ef…Efficacy and Enlightenment: LSD Psychotherapy and the Drug Amendments of 1962 (2012)Efficacy and Enlightenment: L…The "chemical imbalance" explanation for depression: Origins, lay endorsement, and clinical implications. (2007)The "chemical imbalance" expl…The Myth of Reserpine-Induced Depression: Role in the Historical Development of the Monoamine Hypothesis (2003)The Myth of Reserpine-Induced…Monoamine oxidase inhibitors in anxiety disorders (1988)Monoamine oxidase inhibitors …A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety (1973)A study of the clinical effec…A personality scale of manifest anxiety. (1953)Statistical principles in experimental design. (1962)Delineation of two drug-responsive anxiety syndromes (1964)Specificity of lactate infusions in social phobia versus panic disorders (1985)The pharmacology of human anxiety (1990)Psychopharmacological treatment of social phobia: clinical and biochemical effects of brofaromine, a selective MAO-A inhibitor (1992)THE ASSESSMENT OF ANXIETY STATES BY RATING (1959)A RATING SCALE FOR DEPRESSION (1960)Treatment of Endogenous Anxiety With Phobic, Hysterical, and Hypochondriacal Symptoms (1980)The antidepressant era (1998)The creation of psychopharmacology (2002)Introductory Textbook of Psychiatry (2020)Hopelessness depression: A theory-based subtype of depression. (1989)Public conceptions of mental illness: labels, causes, dangerousness, and social distance. (1999)The Epidemiology of Major Depressive Disorder (2003)Neuroessentialism: Theoretical and Clinical Considerations (2015)Comparative Studies of Psychotherapies (1975)A History of Psychiatry: From the Era of the Asylum to the Age of Prozac. (1997)Reputation and Power (2014)Regulation of human research with LSD in the United States (1949-1987) (2017)Why was early therapeutic research on psychedelic drugs abandoned? (2021)Models of Psychedelic-Assisted Psychotherapy: A Contemporary Assessment and an Introduction to EMBARK, a Transdiagnostic, Trans-Drug Model (2022)Human Pharmacology of Ayahuasca: Subjective and Cardiovascular Effects, Monoamine Metabolite Excretion, and Pharmacokinetics (2003)Multiple receptors contribute to the behavioral effects of indoleamine hallucinogens (2011)Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: a preliminary report (2015)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 1973A study of the clinical effects of phenelzine and placebo in the treatment of phobic anxiety132 cited
  • 2003The Myth of Reserpine-Induced Depression: Role in the Historical Development of the Monoamine Hypothesis120 cited
  • 2015Behavioural and neurotoxic effects of ayahuasca infusion (Banisteriopsis caapi and Psychotria viridis) in female Wistar rat102 cited
  • 2012Efficacy and Enlightenment: LSD Psychotherapy and the Drug Amendments of 196298 cited
  • 2007The "chemical imbalance" explanation for depression: Origins, lay endorsement, and clinical implications.87 cited
  • 1988Monoamine oxidase inhibitors in anxiety disorders53 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work